← Leaderboards
Eric V Shusta
University Of Wisconsin Madison
$15,385,532
Attributed
$16,611,386
Total exposure
12
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2006–25$2.5M$1.9M$1.3M$625K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,611,386 · 12
By mechanism
R01$11,671,568 · 7
RC4$1,844,274 · 1
RF1$1,838,781 · 1
R21$1,256,763 · 3
Top collaborators
- Richard Daneman1 shared
- Sean P Palecek1 shared
Most similar at University Of Wisconsin Madison
Same institution · by research overlap
- Jonathan C Makielski$21,469,777
- Robert M. Hauser$36,785,553
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposBlood - Brain Barrier AnatomyBrainBloodEndotheliumNervous System DisorderBlood CirculationProgramsCharacteristicsEndothelial CellsCellsPropertyS DiseaseProteinsSignal TransductionReceptorGenerationsIn VitroMediatingPhenotypeBaseTransport ProcessIn VivoBrain Diseases
Grant awards (43)
New Human Antibodies for CNS Drug Delivery$382,090
R01 · FY2025 · NS · contact PI
New Human Antibodies for CNS Drug Delivery$370,627
R01 · FY2024 · NS · contact PI
Identifying the role of notch3 in brain pericyte function in health and Alzheimer's disease$1,838,781
RF1 · FY2023 · NS · contact PI
New Human Antibodies for CNS Drug Delivery$382,090
R01 · FY2023 · NS · contact PI
New Human Antibodies for CNS Drug Delivery$382,090
R01 · FY2022 · NS · contact PI
Exploring Blood-Brain Barrier Dysfunction in Alzheimer's Disease$380,390
R01 · FY2022 · NS · contact PI
Investigating Pericyte Roles in Blood-Brain Barrier Formation$367,795
R01 · FY2022 · NS · contact PI
New Human Antibodies for CNS Drug Delivery$381,793
R01 · FY2021 · NS · contact PI
Exploring Blood-Brain Barrier Dysfunction in Alzheimer's Disease$380,390
R01 · FY2021 · NS · contact PI
Investigating Pericyte Roles in Blood-Brain Barrier Formation$367,795
R01 · FY2021 · NS · contact PI
Identification of Lamprey Antibodies Capable of Noninvasive Brain Drug Delivery$329,244
R01 · FY2021 · NS · contact PI
Exploring Blood-Brain Barrier Dysfunction in Alzheimer's Disease$380,036
R01 · FY2020 · NS · contact PI
Investigating Pericyte Roles in Blood-Brain Barrier Formation$367,795
R01 · FY2020 · NS · contact PI
Identification of Lamprey Antibodies Capable of Noninvasive Brain Drug Delivery$330,819
R01 · FY2020 · NS · contact PI
Exploring Blood-Brain Barrier Dysfunction in Alzheimer's Disease$379,965
R01 · FY2019 · NS · contact PI
Investigating Pericyte Roles in Blood-Brain Barrier Formation$367,795
R01 · FY2019 · NS · contact PI
Identification of Lamprey Antibodies Capable of Noninvasive Brain Drug Delivery$332,583
R01 · FY2019 · NS · contact PI
Exploring Blood-Brain Barrier Dysfunction in Alzheimer's Disease$392,861
R01 · FY2018 · NS · contact PI
Investigating Pericyte Roles in Blood-Brain Barrier Formation$381,045
R01 · FY2018 · NS · contact PI
Identification of Lamprey Antibodies Capable of Noninvasive Brain Drug Delivery$332,583
R01 · FY2018 · NS · contact PI
RXRalpha and PPARdelta Signaling as Novel Regulators of the Blood-Brain Barrier$385,525
R01 · FY2017 · NS · contact PI
Identification of Lamprey Antibodies Capable of Noninvasive Brain Drug Delivery$332,583
R01 · FY2017 · NS · contact PI
RXRalpha and PPARdelta Signaling as Novel Regulators of the Blood-Brain Barrier$385,525
R01 · FY2016 · NS · contact PI
Using lamprey antibodies to profile the blood-brain barrier$189,035
R21 · FY2016 · NS · contact PI
RXRalpha and PPARdelta Signaling as Novel Regulators of the Blood-Brain Barrier$385,525
R01 · FY2015 · NS · contact PI
Using lamprey antibodies to profile the blood-brain barrier$240,535
R21 · FY2015 · NS · contact PI
RXRalpha and PPARdelta Signaling as Novel Regulators of the Blood-Brain Barrier$381,193
R01 · FY2014 · NS · contact PI
RXRalpha and PPARdelta Signaling as Novel Regulators of the Blood-Brain Barrier$385,660
R01 · FY2013 · NS · contact PI
Proteomic Evaluation of the Blood-Brain Barrier Receptor-Mediated Transportome$272,618
R01 · FY2013 · NS · contact PI
Proteomic Evaluation of the Blood-Brain Barrier Receptor-Mediated Transportome$282,834
R01 · FY2012 · NS · contact PI
Proteomic Evaluation of the Blood-Brain Barrier Receptor-Mediated Transportome$283,151
R01 · FY2011 · NS · contact PI
Human Blood-Brain Barrier Model for CNS Drug Translation$1,844,274
RC4 · FY2010 · AA · contact PI
Proteomic Evaluation of the Blood-Brain Barrier Receptor-Mediated Transportome$289,240
R01 · FY2010 · NS · contact PI
Membrane Proteomics of the Blood-Brain Barrier$281,418
R01 · FY2009 · NS · contact PI
Membrane Proteomics of the Blood-Brain Barrier$164,392
R01 · FY2009 · NS · contact PI
Membrane Proteomics of the Blood-Brain Barrier$281,641
R01 · FY2008 · NS · contact PI
Novel Antibody-Transporter Conjugates for Brain Drug Delivery$179,990
R21 · FY2008 · EY · contact PI
Membrane Proteomics of the Blood-Brain Barrier$281,856
R01 · FY2007 · NS · contact PI
Novel Antibody-Transporter Conjugates for Brain Drug Delivery$216,740
R21 · FY2007 · EY · contact PI
Membrane Proteomics of the Blood-Brain Barrier$288,621
R01 · FY2006 · NS · contact PI
Functional Genomics of the Blood-Brain Barrier$143,408
R21 · FY2004 · AA
Functional Genomics of the Blood-Brain Barrier$143,489
R21 · FY2003 · AA
Functional Genomics of the Blood-Brain Barrier$143,566
R21 · FY2002 · AA